Doctor of Medicine
These providers work together to achieve patient-centered care, using proven best practices to offer better care to you and your family.
Finn Petersen, MD became involved in the first bone marrow transplants (BMT) in Denmark while in medical school, and after medical school orchestrated the first BMT done for acute leukemia in Denmark. After his fellowship, he joined the faculty at the Fred Hutchinson Cancer Research Center in Seattle and rose to the rank of assistant professor. Afterward, Dr. Petersen accepted a position as full professor at the University of Utah. While there he served as medical director and later program director of the Blood and Marrow Transplant Program, which encompassed the University of Utah's and Intermountain Healthcare's adult BMT programs as well as a pediatric BMT program at Primary Children's Medical Center. He later consolidated adult BMT at the Intermountain Healthcare's LDS Hospital, developing an integrated BMT and hematological malignancy program (blood cancer), focusing on acute leukemia care. In 2015, Dr. Petersen was named one of Utah's Health Care Heroes for his work in establishing and growing a hematological malignancy center of excellence within Intermountain Healthcare.
Dr. Petersen is currently working to develop and lead an allogenic (donor) blood and marrow transplant program at St. Luke's Mountain States Tumor Institute as part of our new "heme-malignancy" (blood cancer) program.
Dr. Petersen is internationally known for his long-standing work focusing on complications related to hematopoietic stem cell transplantation, and is an author and co-author of over 180 peer reviewed scientific publications, books, or book chapters. He is a frequent invited speaker at national and international conferences on topics of infections and treatment-related complications in blood and marrow transplantation and acute leukemia treatment.
Petersen, F.B., Lynch, M.H.; Clift, R.A.; Appelbaum, F.R., Sanders, J.E.; Bensinger, W.I., Benyunes, M.C., Doney, K., Fefer, A., Martin., P., Storb., R., Sullivan, K.M., Witherspoon, R., Weiden, P., Thomas, E.D., Hansen, J.A.: Buckner, C.D.:
Autologous marrow transplantation for patients with acute myelogenous leukemia in untreated first relapse or in second remission.
J. Clin. Onc. 7: 1353-1360, 1993.
Petersen, F.B. and Bearman, S.I.:
Preparative regimens and their toxicity. In: G. Forman, E.D. Thomas, K. Blume (ed.)
Bone Marrow Transplantation, Blackwell Scientific Publications Inc., Boston, Massachusetts: 79-95; 1994.
Petersen, F.B., Ford, C.D.:
Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
Curr Opin Oncol 2009;21(S1)7-9.
Ford C.D., Lopansri B.K., Gazdik M.A., Snow G.L., Webb B.J., Konopa K.L., Petersen F.B.:
The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.
Transpl Infect Dis. 2015 Oct;17(5):688-94.
Webb B.J., Brunner A., Ford C.D., Gazdik M.A., Petersen F.B., Hoda D.:
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Transpl Infect Dis. 2016, May 23. doi: 10.1111/tid.12550. [Epub ahead of print]